On December 14, Shanghai Municipal Science & Technology Commission and Shanghai Technology Innovation Center held the “2021 Annual Conference on High and New Technology Achievement Transformation in Shanghai”. The 100 best projects of high and new technology achievement transformation of 2020 in Shanghai were unveiled at the conference, including the “sodium hyaluronate injection (new technology)” project of Haohai Biological Technology.  

The designation of high technology achievement transformation projects focused on the high and new technology industrial sectors, playing a guiding and demonstrative role in driving the development of high and new technology industries and cultivating new economic engines. This time, a total of 10 biopharmaceutical companies across the city were selected, while a total of 8 corporate projects from Songjiang District were evaluated, of which the “sodium hyaluronate injection (new technology)” project of Haohai Biological Technology is the only biopharmaceutical project. So far, Haohai Biological Technology has a total of 11 projects that won the honorary title.

Photo: sodium hyaluronate injection products of Haohai Biological Technology

With its combination of sodium hyaluronate injection + medical chitin, Haohai Biological Technology’s orthopedic joint cavity viscoelastic supplement product continues leading the domestic market in terms of market share. According to a 2021 research report published by Guangzhou Point Pharmaceutical Information Co., Ltd, Haohai Biological Technology has secured the first spot on China’s orthopedic joint cavity viscoelastic supplement market for 7 years in a row, with a market share of 43.30% in 2020.